Search - tctmd.com

Displaying 361 - 379 of 379

Presentation TCT 2012

5-year results of treatment of Unprotected Left Main Stenosis by CABG or PCI with Sirolimus eluting stent. A multicenter, randomized trial

Presenter: Enno Boudriot, Holger Thiele, Franz J. Neumann, Michael Gick, Bruno Reichard, Peter Boekstegers, Harald Mudra, Florian Beier, Thomas Walther, Friedrich W. Mohr, Gerhard Schuler

January 03, 2012

News Daily News

Meta-analysis: Everolimus-Eluting Stents Reduce Thrombosis vs. Other DES

September 14, 2011

News Daily News

ISAR-CABG Published: DES Preferred for Saphenous Vein Graft Lesions

Jason Kahn

September 12, 2011

News Conference News

Two Trials Show Favorable Results with XIENCE V vs. Earlier DES, BMS

September 02, 2011

News Conference News

RESET: Largest Study to Date of Xience, Cypher Shows Noninferiority

August 31, 2011

News Daily News

ESSENCE-DIABETES Published: Xience, Cypher Equally Equipped to Treat Diabetics

Caitlin E. Cox

August 03, 2011

News Conference News

Meta-analysis: Biodegradable Polymer DES Reduce Stent Thrombosis, TLR at 3 Years

Caitlin E. Cox

May 20, 2011

News Daily News

Antithrombin Plus Preloading with Clopidogrel May Reduce Stent Thrombosis

L.A. McKeown

April 15, 2011

News Conference News

PRECOMBAT: PCI with Sirolimus Stent Equivalent to CABG in Left Main Disease

April 05, 2011

News Conference News

ISAR-CABG: DES Superior to BMS in Saphenous Vein Graft Lesions

Jason Kahn

April 04, 2011

News Conference News

For Bifurcations, 1 Stent Just as Good as 2 Out to 5 Years

Jason Kahn

April 03, 2011

News Daily News

Study Compares Stents, Surgery in Diabetics with Multivessel Disease

Caitlin E. Cox

March 23, 2011

News Daily News

Restenosis After Left Main Stenting Does Not Affect Long-term Prognosis

March 14, 2011

News Daily News

Studies Support DES Use in Diabetics, But Results Vary by Device

Caitlin E. Cox

March 08, 2011

News Daily News

For Bifurcations, 2 Stents Better Than 1 at Reducing Revascularizations

February 13, 2011

News Daily News

Randomized Trial Clouds Debate Over DES, CABG in Left Main Disease

Jason Kahn

January 23, 2011

News Daily News

Meta-Analysis Confirms Superiority of Simple Stenting for Bifurcations

L.A. McKeown

January 10, 2011

News Daily News

Final Kissing Balloon Unnecessary in Single-Stent Approach to Bifurcation Lesions

Caitlin E. Cox

January 04, 2011

News Daily News

TCTMD’s Top 10 Most Popular News Stories for 2010

Jason Kahn

January 02, 2011

Advertisement

5-year results of treatment of Unprotected Left Main Stenosis by CABG or PCI with Sirolimus eluting stent. A multicenter, randomized trial

Meta-analysis: Everolimus-Eluting Stents Reduce Thrombosis vs. Other DES

ISAR-CABG Published: DES Preferred for Saphenous Vein Graft Lesions

Two Trials Show Favorable Results with XIENCE V vs. Earlier DES, BMS

RESET: Largest Study to Date of Xience, Cypher Shows Noninferiority

ESSENCE-DIABETES Published: Xience, Cypher Equally Equipped to Treat Diabetics

Meta-analysis: Biodegradable Polymer DES Reduce Stent Thrombosis, TLR at 3 Years

Antithrombin Plus Preloading with Clopidogrel May Reduce Stent Thrombosis

PRECOMBAT: PCI with Sirolimus Stent Equivalent to CABG in Left Main Disease

ISAR-CABG: DES Superior to BMS in Saphenous Vein Graft Lesions

For Bifurcations, 1 Stent Just as Good as 2 Out to 5 Years

Study Compares Stents, Surgery in Diabetics with Multivessel Disease

Restenosis After Left Main Stenting Does Not Affect Long-term Prognosis

Studies Support DES Use in Diabetics, But Results Vary by Device

For Bifurcations, 2 Stents Better Than 1 at Reducing Revascularizations

Randomized Trial Clouds Debate Over DES, CABG in Left Main Disease

Meta-Analysis Confirms Superiority of Simple Stenting for Bifurcations

Final Kissing Balloon Unnecessary in Single-Stent Approach to Bifurcation Lesions

TCTMD’s Top 10 Most Popular News Stories for 2010

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content